Publications

1. Chapman LE, Iskander JK, Chen RT, Neff J, Birkhead GS, Poland G, Gray GC, Siegel J, Sepkowitz K, Robertson RM, Yancy C, Guerra FA, Gardner P, Modlin JF, Maurer T, Berger T, Flanders WD, Shope R. A process for sentinel case review to assess causal relationships between smallpox vaccination and adverse outcomes, 2003–2004. Clinical infectious diseases. 2008;46(Supplement_3):S271-S293.

2. Donahue JG, Kieke BA, Szilagy PG, Blumkin AK, Hilgemann D, Flanders WD et al. Can the rolling cross-sectional survey design be used to estimate the effectiveness of influenza vaccines? Vaccine. 2014;32(48):6440-6444.

3. Miller MA, Flanders WD. A model to estimate the probability of hepatitis B-and Haemophilus influenzae type b-vaccine uptake into national vaccination programs. Vaccine. 2000;18(21):2223-2230.

4. Neff J, Modlin J, Birkhead GS, Poland G, Robertson RM, Sepkowitz K, Yancy C, Gardner P, Gray GC, Maurer T, Siegel J, Guerra F, Berger T, Flanders WD, Shope R. Monitoring the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the advisory committee on immunization practices and the Armed Forces Epidemiological Board. Clinical infectious diseases. 2008;46(Supplement_3):S258-S270.

5. Michael Goodman, Jianheng Li, W. Dana Flanders, Duncan Mahood, Laura G. Anthony, Qi Zhang, Judy S. LaKind. Epidemiology of PCBs and neurodevelopment: Systematic assessment of multiplicity and completeness of reporting. Global Epidemiology, Volume 2, 2020, 100040, ISSN 2590-1133.

6. Flanders WD, Flanders WD, Goodman M. The association of voter turnout with county-level coronavirus disease 2019 occurrence early in the pandemic. Annals of epidemiology. 2020;49:42-49.

7. Alsnes IV, Munkvik M, Flanders WD, Øyane N. How well did Norwegian general practice prepare to address the COVID-19 pandemic? Family medicine and community health. 2020;8(4).

8. Flanders WD, Garber MD: Is the Smog Lifting?: Causal Inference in Environmental Epidemiology. Epidemiology 2019, 30:317-20. Accessible here.

9. Goodman M, Adams N, Corneil T, Kreukels B, Motmans J, Coleman E. Size and distribution of transgender and gender non-conforming populations. Endocrinology and Metabolism Clinics of North America 2019 8(2):303-321

10. Lally, C., Jones, C., Farwell, W., Reyna, S. P., Cook, S. F., & Flanders, W. D. Indirect estimation of the prevalence of spinal muscular atrophy Type I, II, and III in the United States. Orphanet journal of rare diseases, 2017;12(1):175. Accessible here.

11. Nash R, Goodman M, Lin C, Freedman R, Dominici L, Ward K, Jemal A.  State variation in contralateral prophylactic mastectomy among U.S. women diagnosed with invasive unilateral early stage breast cancer, 2004-2012 JAMA Surgery 2017 152(7):648-657

12. Goodman M, Naiman D, LaKind J. Systematic review of the literature on triclosan and health outcomes in humans Critical Reviews in Toxicology 2018 48(1):1-51. Accessible here.

13. Flanders WD, Ye D: Limits for the Magnitude of M-bias and Certain Other Types of Structural Selection Bias. Epidemiology 2019, 30:501-8.

14. Flanders WD, Strickland MJ, Klein M: A new method for partial correction of residual confounding in time-series and other observational studies. American journal of epidemiology 2017, 185:941-9. Accessible here.

15. Flanders WD, Klein M, Mirabelli MC: Conditions for valid estimation of causal effects on prevalence in cross-sectional and other studies. Annals of epidemiology 2016, 26:389-94. e2. Accessible here.

16. Flanders WD, Eldridge RC, McClellan W: A nearly unavoidable mechanism for collider bias with index-event studies. Epidemiology 2014, 25:762-4.